Memorial Sloan Kettering Cancer Center
Grantee
Areas of Interest
Organization Type
Region
Funding date
Website
Mission
Memorial Sloan Kettering was founded in 1884, and today is a world leader in patient care, research, and educational programs. Their mission is ending cancer for life.
Our support
The Pershing Square Foundation allocated funding towards COVID-19 research undertaken by the institutions associated with its talented PSSCRA community. We sought our scientific advisors’ knowledge and expertise to solicit proposals from researchers at their respective institutions whose work they deemed exceptional and could not only make an impact on the SARS-CoV-2 virus, but also other diseases. Our hope is that the synergy amongst cancer research, immunotherapy, genetics, and epigenetics might shed new light on COVID research, expand our basic scientific knowledge, and strengthen our arsenal for current and future health crises. This funding to Memorial Sloan Kettering went to Drs. Benjamin Greenbaum, Matthew Hellmann, and Jedd Wolchok to support their project “Etiology and Immune Repertoire Evolution in SARS-CoV-2 in Patients Treated with Checkpoint Blockade Immunotherapies,” Dr. Christine Mayr to support her project “A role for RNA as checkpoint for protein complex assembly” and Drs. Santosha Vardhana and Omar Abdel-Wahab to support their project “Leveraging cancer-driven immune dysregulation to understand and enhance anti-COVID-19 immunity.”
The Pershing Square Foundation has supported the lab of Dr. Christine Mayr for the research project "Molecular Function of TIS Granules."